Fustibal Competitors and Similar CompaniesClear all
Fustibal's competitors and similar companies include T-knife, Nilogen Oncosystems, ACROBiosystems and Rhapsody Biologics.
 Fustibal Fustibal is a biotechnology company that develops antibody-based nanomedicines for multi-targeted cancer therapy. |  T-knife T-knife is a biotech company developing T cell receptors (TCRs) for T cell therapy of cancer. |  Nilogen Oncosystems Nilogen is a biotechnology company providing solutions in immuno-oncology drug development and personalized cancer care. |  ACROBiosystems ACROBiosystems is a manufacturer of recombinant proteins committed to supporting cancer immunotherapy. |  Rhapsody Biologics Rhapsody Biologics is a company that creates a versatile Personalized Peptide Vaccine (PPV) platform to predict and optimize peptide vaccines for use at an individual and population level. | |
Founding Date | Founding Date N/A | Founding Date 2018 | Founding Date 2013 | Founding Date 2010 | Founding Date 2009 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Berlin, DE HQ | Locations Tampa, US HQ | Locations Newark, US HQ 杭州市, CN Cambridge, US Newark, US San Jose, US | Locations HQ |
Employees | Employees 2 | Employees 834% increase | Employees 157% increase | Employees 1522% increase | Employees 6 |
For sources of this data, please see the company profile
View Company Profiles
T-knife
HQ
Berlin, DE
Employees
83↑ 4% increase
T-knife is a biotech company developing T cell receptors (TCRs) for T cell therapy of cancer.
View companyNilogen Oncosystems
HQ
Tampa, US
Employees
15↑ 7% increase
Nilogen is a biotechnology company providing solutions in immuno-oncology drug development and personalized cancer care.
View companyACROBiosystems
HQ
Newark, US
Employees
152↑ 2% increase
ACROBiosystems is a manufacturer of recombinant proteins committed to supporting cancer immunotherapy.
View companyRhapsody Biologics
HQ
Employees
6
Rhapsody Biologics is a company that creates a versatile Personalized Peptide Vaccine (PPV) platform to predict and optimize peptide vaccines for use at an individual and population level.
View company